• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD
Click for more information
2.21% 69.5¢

ZELIRA THERAPEUTICS LIMITED

Market Cap $7.886M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription [Rx] business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter [OTC] products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ZLD
Ann: March 2024 Quarterly Activities Report 		30/04/24 2 434
30/04/24 Last post  gregwallis Comments Created with Sketch.  2  Views Created with Sketch.  434 
ZLD
Ann: Appendix 4C Cash Flow Report 		29/04/24 0 198
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  198 
ZLD
Ann: Appendix 4C Cash Flow Report 		24/04/24 6 2.7K
24/04/24 Last post  cue Comments Created with Sketch.  6  Views Created with Sketch.  2.7K 
ZLD
Ann: Zelira receives $919,000 R&D Tax Incentive Scheme Refund 		16/04/24 2 743
16/04/24 Last post  Viper_00 Comments Created with Sketch.  2  Views Created with Sketch.  743 
ZLD
Summary 		03/04/24 37 17K
03/04/24 Last post  FiSaver Comments Created with Sketch.  37  Views Created with Sketch.  17K 
ZLD
Ann: Appendix 4D & FY24 Interim Financial Report 		23/02/24 9 2.7K
23/02/24 Last post  cue Comments Created with Sketch.  9  Views Created with Sketch.  2.7K 
ZLD
News: ZLD Zelira Therapeutics Says HY Net Loss Attributable A$34.1 Million Versus Loss A$3.3... 		22/02/24 0 211
22/02/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  211 
ZLD
Ann: December 2023 Quarterly Activities Report 		31/01/24 1 568
31/01/24 Last post  PutUsernameHere Comments Created with Sketch.  1  Views Created with Sketch.  568 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4C Cash Flow Report
29 Apr 17:10
 
March 2024 Quarterly Activities Report
29 Apr 17:09
 
Zelira receives $919,000 R&D Tax Incentive Scheme Refund
15 Apr 11:16
 
Appendix 4D & FY24 Interim Financial Report
22 Feb 16:57
 
Appendix 4C Cash Flow Report
31 Jan 12:14
 
December 2023 Quarterly Activities Report
31 Jan 12:13
 
View More arrow Created with Sketch.

Featured News

NEWS Quarterly Wrap: Frontier Energy & Haranga Resources
right-arrow Created with Sketch.
NEWS Dreadnought hits expected mineralisation through drilling at Yilgarn targets
right-arrow Created with Sketch.
TEA Newest ASX entrant, Tasmea Ltd, up 12.5% on maiden debut
right-arrow Created with Sketch.
BB1 Why Princeton Professor rates BlinkLab's autism & ADHD screening app
right-arrow Created with Sketch.
EV1 Evolution Energy flags successful anode testwork in potential game-changer
right-arrow Created with Sketch.
HLX Gold anomalies across several kilometres impress Helix in NSW
right-arrow Created with Sketch.

(20min delay)
Last
69.5¢ 		Change
0.015(2.21%) 		Mkt cap ! $7.886M
Open High Low Value Volume
68.0¢ 72.0¢ 68.0¢ $480 687

Buyers (Bids)

No. Vol. Price($)
1 426 69.5¢
 

Sellers (Offers)

Price($) Vol. No.
72.0¢ 1944 3
View Market Depth
Last trade - 15.35pm 01/05/2024 (20 minute delay) ?
ZLD (ASX) Chart

Top Stories

Carnarvon revs up for revised Dorado Development

The Dorado discovery appears on again, with Carnarvon Energy announcing the JV completing a revision of the project’s design to optimise capital costs and accelerate FID by the end of 2024.
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Recharged Prospects: 'Watts' on the horizon for copper & lithium The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
Provident Aurum's off-market bid sends Sihayo shares soaring Small-cap mineral and gold explorer, Sihayo Gold (ASX:SIH) shares have soared, on news that the company has received intentions from Provident Aurum Pte to make an off-market takeover offer to acquire all shares of Sihayo Gold.

Featured News

BB1 Why Princeton Professor rates BlinkLab's autism & ADHD screening app
right-arrow Created with Sketch.
NEWS Wealth Within eyes healthcare sector strength
right-arrow Created with Sketch.
EV1 Evolution Energy flags successful anode testwork in potential game-changer
right-arrow Created with Sketch.
CXO Core Lithium is running off stockpiles – and they'll be depleted by FY25
right-arrow Created with Sketch.
BPH BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11
right-arrow Created with Sketch.
LU7 Lithium Universe ends the quarter on the charge for Quebec Refinery development
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.